Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

1754studies shown

Showing 85-96 of 1,754

Drug study icon

RecruitingNCT05664516

The Effects of Oxytocin in Adults With Binge-Eating disorders

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

Eating disordersDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Eating disorders

Drug study icon

RecruitingNCT07615426

Aticaprant for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Janssen Research & Development, LLC
Condition: Schizophrenia

Behavioral study icon

RecruitingNCT07487818

Vagal Nerve Stimulation In Conjunction With NRT For Smoking Cessation

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: Mayo Clinic
Condition: Addiction

Drug study icon

RecruitingNCT06696755

Adverse Events and Change for Bipolarity

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: AbbVie
Condition: Bipolarity

Drug study icon

RecruitingNCT07145918

Adverse Events, Change for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: AbbVie
Condition: Schizophrenia

Drug study icon

RecruitingNCT04777357

Change for depression

The registry lists this study as recruiting. Study locations are listed in the United States and in Russia.

In United States

Bipolarity, DepressionDrugFrom 10 Years to 17 Years

Countries: United States, Russia
Sponsor: AbbVie
Condition: Bipolarity, Depression

Drug study icon

RecruitingNCT07276997

Change in Disease Activity and Adverse Events of Oral Icalcaprant in adults with Major Depressive Disorder

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: AbbVie
Condition: Depression

Drug study icon

RecruitingNCT05511363

KarXT for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in the United Kingdom, ...

In United States

SchizophreniaDrugFrom 55 Years to 90 Years

Countries: United States, France, United Kingdom, ...
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition: Schizophrenia

Drug study icon

RecruitingNCT06126224

KarXT for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Canada, in the United Kingdom, ...

In United States

SchizophreniaDrugFrom 55 Years to 90 Years

Countries: United States, Canada, United Kingdom, ...
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition: Schizophrenia

Drug study icon

RecruitingNCT06540833

ITI-1284 for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Bulgaria, in Croatia, ...

In United States

SchizophreniaDrugOver 55 Years

Countries: United States, Bulgaria, Croatia, ...
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Schizophrenia

Drug study icon

RecruitingNCT06887192

ML-007C-MA for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Canada, ...

In United States

SchizophreniaDrugFrom 55 Years to 90 Years

Countries: United States, France, Canada, ...
Sponsor: MapLight Therapeutics
Condition: Schizophrenia

Drug study icon

RecruitingNCT06524830

VLS-01 Buccal Film, Compared to Placebo for treatment-resistant depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in Canada, ...

In United States

DepressionDrugFrom 18 Years to 65 Years

Countries: United States, Australia, Canada, ...
Sponsor: atai Therapeutics, Inc.
Condition: Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.